PF4 and systemic sclerosis: It has been shown that iloprost, a synthetic prostaglandin and one of the most used drugs in the treatment of vascular manifestation of SSc [83], is able to dose-dependently inhibit IFN-α induced by CXCL4–DNA and CXCL4–RNA complex stimulation in pDCs.